Liu et al. recently found that treatment with the KDM7B inhibitor daminozide reduced the proliferation of CRC cells and lowered the expression levels of the oncogenes KRAS, BRAF, and c-Myc in vitro [172]. This evidence concerns the gene MYC and colorectal carcinoma.